{"id":"W4386282368","doi":"10.1016/s2152-2650(23)00484-6","title":"POSTER: AML-469 Ivosidenib + Azacitidine vs Placebo + Azacitidine in Patients With Newly-Diagnosed Acute Myeloid Leukemia: Updated Long-term Efficacy and Safety Results From the AGILE Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; College of Medicine, Catholic University of Korea; Universitätsklinikum Heidelberg; Catholic University of Korea; Fakultní nemocnice Hradec Králové; Johns Hopkins University; Duke Cancer Institute; University of Miami; Augusta University; University of Pennsylvania; Chang Gung Medical Foundation; Deutsches Krebsforschungszentrum; Seoul St. Mary's Hospital, Catholic University of Korea","keywords":"Azacitidine; Myeloid leukemia; Medicine; Placebo; Oncology; Term (time); Internal medicine; Biology; Pathology; Alternative medicine; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001500438,0.0008049534,0.002125221,0.0003068685,0.000273435,0.001212918,0.000603823,0.0008401918,0.00944606],"category_scores_gemma":[0.001991761,0.0003626137,0.002190752,0.0003438331,0.0004034062,0.000624731,0.0003449788,0.002980404,0.001221177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005398911,"about_ca_system_score_gemma":0.0006426151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000821218,"about_ca_topic_score_gemma":0.002372527,"domain_scores_codex":[0.9995196,0.0002500924,0.00004460316,0.00006258174,0.00006642322,0.00005687529],"domain_scores_gemma":[0.998929,0.0004241206,0.0003006452,0.00005336549,0.00007054793,0.0002224088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7739079,0.003061701,0.005262269,0.002262242,0.007455424,0.00008799121,0.0000917846,0.0008778729,0.005775128,0.0003230834,0.01359472,0.1873],"study_design_scores_gemma":[0.8347341,0.08878127,0.04421833,0.0005869148,0.01061398,0.00025313,0.0001029075,0.0006164233,0.002524298,0.000609075,0.01688142,0.00007817393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8468641,0.1088345,0.001280178,0.007974933,0.00428912,0.001845396,0.01248353,0.0003610057,0.01606728],"genre_scores_gemma":[0.9312337,0.03862967,0.002176869,0.007461707,0.002775912,0.0009244088,0.006420994,0.00007717407,0.01029959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00944606,"threshold_uncertainty_score":0.03160018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02450396359082936,"score_gpt":0.3143090550814487,"score_spread":0.2898050914906193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}